NIH-funded research NIH-funded research

Understanding how essential membrane transporters work

Official title: Mechanistic studies of essential membrane transporters

Funded at University of Colorado Denver · NIH-10763764 · Data updated 2026-11-12

This study is looking at how certain proteins in our cells work to move important substances in and out, which could help create new medicines for people with diseases linked to these proteins.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$346,711
NIH project number1R35GM151970-01
Project IDNIH-10763764 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to membrane transport dysfunction or those who may benefit from targeted drug therapies.

Less likely to help

Patients with conditions unrelated to membrane transporters or those who do not require targeted drug therapies may not benefit from this research.

What this research studies

This research investigates the fundamental mechanisms of membrane transporters that are crucial for cellular life and often linked to human diseases. The team aims to explore the structure-function relationships of these transporters, focusing on their substrate selectivity and the development of small molecules that can target them effectively. By employing a multidisciplinary approach that includes biochemistry, microbiology, and molecular dynamics, the research seeks to uncover how these transporters operate and how they can be manipulated for therapeutic purposes. Patients may benefit from the potential development of new drugs targeting these transporters.

Why it matters

Potential benefit: If successful, this research could lead to the development of new drugs that specifically target membrane transporters, improving treatment options for various diseases.

How similar studies have gone: Previous research has shown promise in understanding membrane proteins and developing targeted therapies, indicating that this approach has potential for success.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Zheng, Hongjin — University of Colorado Denver
  • Study coordinator: Zheng, Hongjin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.